BMO Capital Downgrades Acadia Healthcare (ACHC) to Market Perform

Go back to BMO Capital Downgrades Acadia Healthcare (ACHC) to Market Perform

Acadia Healthcare (ACHC) PT Maintained at $48 at Stephens on 2Q Report; 'Sell Off Overdone'

August 1, 2018 7:27 AM EDT

Stephens maintained its price target on Acadia Healthcare (NASDAQ: ACHC) at $48.00 while maintaining a Overweight rating, following the company's second quarter earnings report.

Analyst Dana Hambly suggests the sell-off in shares ACHC is overdone, as the company reported second quarter earnings per share... More

Stephens Reiterated Overweight on Acadia Healthcare (ACHC) Following 2Q

August 1, 2018 7:13 AM EDT

Stephens reiterated an Overweight rating and $48.00 price target on Acadia Healthcare (NASDAQ: ACHC) following the company's 2Q earnings report. U.S. revenues came in at $487.5 million missing the consensus of $494.7 million. SS revenue growth of 5.0% was driven by a 1.9% increase in SS... More

Acadia Healthcare (ACHC) Reports In-Line Q2 EPS, SSS Rose 5.2%

July 30, 2018 4:08 PM EDT

Acadia Healthcare (NASDAQ: ACHC) reported Q2 EPS of $0.70, in-line with the analyst estimate of $0.70. Revenue for the quarter came in at $765.7 million versus the consensus estimate of $767.88 million.

GUIDANCE:

Acadia Healthcare sees FY2018 EPS of $2.52-$2.56, Sees FY2018 revenues of $3.02-3.06... More